<?xml version="1.0" encoding="UTF-8"?>
<billStatus>
  <bill>
    <originChamber>House</originChamber>
    <relatedBills />
    <cboCostEstimates />
    <cosponsors>
      <item>
        <lastName>Brat</lastName>
        <isOriginalCosponsor>True</isOriginalCosponsor>
        <middleName />
        <bioguideId>B001290</bioguideId>
        <party>R</party>
        <identifiers>
          <lisID>2203</lisID>
          <gpoId />
          <bioguideId>B001290</bioguideId>
        </identifiers>
        <state>VA</state>
        <sponsorshipDate>2017-02-13</sponsorshipDate>
        <sponsorshipWithdrawnDate />
        <fullName>Rep. Brat, Dave [R-VA-7]</fullName>
        <district>7</district>
        <firstName>Dave</firstName>
      </item>
    </cosponsors>
    <subjects>
      <billSubjects>
        <legislativeSubjects>
          <item>
            <name>Business records</name>
          </item>
          <item>
            <name>Civil actions and liability</name>
          </item>
          <item>
            <name>Drug safety, medical device, and laboratory regulation</name>
          </item>
          <item>
            <name>Drug therapy</name>
          </item>
          <item>
            <name>Health technology, devices, supplies</name>
          </item>
          <item>
            <name>Long-term, rehabilitative, and terminal care</name>
          </item>
          <item>
            <name>Prescription drugs</name>
          </item>
          <item>
            <name>Retail and wholesale trades</name>
          </item>
          <item>
            <name>Trade restrictions</name>
          </item>
        </legislativeSubjects>
        <policyArea>
          <name>Health</name>
        </policyArea>
      </billSubjects>
    </subjects>
    <actions>
      <item>
        <actionDate>2017-02-17</actionDate>
        <committee>
          <systemCode>hsif14</systemCode>
          <name>Health Subcommittee</name>
        </committee>
        <links />
        <sourceSystem>
          <name>House committee actions</name>
          <code>1</code>
        </sourceSystem>
        <text>Referred to the Subcommittee on Health.</text>
        <type>Committee</type>
      </item>
      <item>
        <text>Referred to the House Committee on Energy and Commerce.</text>
        <type>IntroReferral</type>
        <committee>
          <systemCode>hsif00</systemCode>
          <name>Energy and Commerce Committee</name>
        </committee>
        <actionDate>2017-02-13</actionDate>
        <links />
        <sourceSystem>
          <name>House floor actions</name>
          <code>2</code>
        </sourceSystem>
        <actionCode>H11100</actionCode>
      </item>
      <item>
        <text>Introduced in House</text>
        <type>IntroReferral</type>
        <committee />
        <actionDate>2017-02-13</actionDate>
        <links />
        <sourceSystem>
          <name>Library of Congress</name>
          <code>9</code>
        </sourceSystem>
        <actionCode>Intro-H</actionCode>
      </item>
      <item>
        <text>Introduced in House</text>
        <type>IntroReferral</type>
        <committee />
        <actionDate>2017-02-13</actionDate>
        <links />
        <sourceSystem>
          <name>Library of Congress</name>
          <code>9</code>
        </sourceSystem>
        <actionCode>1000</actionCode>
      </item>
      <actionByCounts>
        <houseOfRepresentatives>4</houseOfRepresentatives>
      </actionByCounts>
      <actionTypeCounts>
        <introducedInTheHouse>1</introducedInTheHouse>
        <introducedInHouse>1</introducedInHouse>
        <placeholderTextForH>1</placeholderTextForH>
        <billReferrals>1</billReferrals>
      </actionTypeCounts>
    </actions>
    <amendments />
    <titles>
      <item>
        <titleType>(Extracted from GPO) Short Titles as Introduced</titleType>
        <parentTitleType />
        <title>Compassionate Freedom of Choice Act of 2017</title>
        <chamberName />
        <chamberCode />
      </item>
      <item>
        <titleType>Short Titles as Introduced</titleType>
        <parentTitleType />
        <title>Compassionate Freedom of Choice Act of 2017</title>
        <chamberName />
        <chamberCode />
      </item>
      <item>
        <titleType>Official Title as Introduced</titleType>
        <parentTitleType />
        <title>To allow the manufacture, importation, distribution, and sale of investigational drugs and devices intended for use by terminally ill patients who execute an informed consent document, and for other purposes.</title>
        <chamberName />
        <chamberCode />
      </item>
      <item>
        <titleType>Display Title</titleType>
        <parentTitleType />
        <title>Compassionate Freedom of Choice Act of 2017</title>
        <chamberName />
        <chamberCode />
      </item>
    </titles>
    <policyArea>
      <name>Health</name>
    </policyArea>
    <laws />
    <notes />
    <updateDate>2017-07-20T16:56:14Z</updateDate>
    <committeeReports />
    <introducedDate>2017-02-13</introducedDate>
    <constitutionalAuthorityStatementText><![CDATA[<pre>From the Congressional Record Online through the Government Publishing Office [<a href='http://www.gpo.gov'>www.gpo.gov</a>]By Mr. GRIFFITH:H.R. 1020.Congress has the power to enact this legislation pursuantto the following:This bill is enacted pursuant to the power granted toCongress under Article I, Section 8 of the United StatesConstitution.[Page H1126]</pre>]]></constitutionalAuthorityStatementText>
    <committees>
      <billCommittees>
        <item>
          <type>Standing</type>
          <chamber>House</chamber>
          <name>Energy and Commerce Committee</name>
          <activities>
            <item>
              <name>Referred to</name>
              <date>2017-02-13T17:02:20Z</date>
            </item>
          </activities>
          <subcommittees>
            <item>
              <activities>
                <item>
                  <name>Referred to</name>
                  <date>2017-02-17T17:34:16Z</date>
                </item>
              </activities>
              <name>Health Subcommittee</name>
              <systemCode>hsif14</systemCode>
            </item>
          </subcommittees>
          <systemCode>hsif00</systemCode>
        </item>
      </billCommittees>
    </committees>
    <billType>HR</billType>
    <billNumber>1020</billNumber>
    <title>Compassionate Freedom of Choice Act of 2017</title>
    <calendarNumbers />
    <sponsors>
      <item>
        <party>R</party>
        <byRequestType />
        <fullName>Rep. Griffith, H. Morgan [R-VA-9]</fullName>
        <district>9</district>
        <state>VA</state>
        <middleName>Morgan</middleName>
        <firstName>H.</firstName>
        <identifiers>
          <lisID>2070</lisID>
          <bioguideId>G000568</bioguideId>
          <gpoId>8200</gpoId>
        </identifiers>
        <lastName>Griffith</lastName>
        <bioguideId>G000568</bioguideId>
      </item>
    </sponsors>
    <recordedVotes />
    <version>1.0.0</version>
    <summaries>
      <billSummaries>
        <item>
          <lastSummaryUpdateDate>2017-03-03T16:24:37Z</lastSummaryUpdateDate>
          <name>Introduced in House</name>
          <text><![CDATA[<p><b>Compassionate Freedom of Choice Act of 2017</b></p> <p>This bill amends the Federal Food, Drug, and Cosmetic Act to declare that nothing in that Act or in the Public Health Service Act prevents or restricts, and the Food and Drug Administration (FDA) may not prevent or restrict, the manufacture, importation, distribution, or sale of drugs or medical devices that are intended for terminally ill patients, have been the subject of a clinical trial, and have not been approved by the FDA.</p> <p>The FDA may not require the disclosure, collection, or reporting of certain information concerning such drugs or devices. The sponsor of a clinical trial may voluntarily disclose, collect, or report such information to the FDA.</p> <p>Except in the case of gross negligence or willful misconduct, a person who manufactures, imports, distributes, prescribes, or administers such a drug or device is not liable under state or federal law for loss, damage, or injury from the development, testing, production, acquisition, use, safety, or effectiveness of the drug or device.</p>]]></text>
          <actionDesc>Introduced in House</actionDesc>
          <versionCode>00</versionCode>
          <actionDate>2017-02-13</actionDate>
          <updateDate>2017-02-13T05:00:00Z</updateDate>
        </item>
      </billSummaries>
    </summaries>
    <latestAction>
      <text>Referred to the Subcommittee on Health.</text>
      <links />
      <actionDate>2017-02-17</actionDate>
    </latestAction>
    <createDate>2017-02-14T05:20:34Z</createDate>
    <congress>115</congress>
  </bill>
  <dublinCore xmlns:dc="http://purl.org/dc/elements/1.1/">
    <dc:format>text/xml</dc:format>
    <dc:language>EN</dc:language>
    <dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
    <dc:contributor>Congressional Research Service, Library of Congress</dc:contributor>
    <dc:description>This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.</dc:description>
  </dublinCore>
</billStatus>

